234 related articles for article (PubMed ID: 21785078)
1. Radiofrequency ablation of medically inoperable stage IA non-small cell lung cancer: are early posttreatment PET findings predictive of treatment outcome?
Yoo DC; Dupuy DE; Hillman SL; Fernando HC; Rilling WS; Shepard JA; Siegel BA
AJR Am J Roentgenol; 2011 Aug; 197(2):334-40. PubMed ID: 21785078
[TBL] [Abstract][Full Text] [Related]
2. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.
Singnurkar A; Solomon SB; Gönen M; Larson SM; Schöder H
J Nucl Med; 2010 Dec; 51(12):1833-40. PubMed ID: 21078787
[TBL] [Abstract][Full Text] [Related]
3. Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial.
Dupuy DE; Fernando HC; Hillman S; Ng T; Tan AD; Sharma A; Rilling WS; Hong K; Putnam JB
Cancer; 2015 Oct; 121(19):3491-8. PubMed ID: 26096694
[TBL] [Abstract][Full Text] [Related]
4. Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: preliminary results.
Okuma T; Okamura T; Matsuoka T; Yamamoto A; Oyama Y; Toyoshima M; Koyama K; Inoue K; Nakamura K; Inoue Y
Ann Nucl Med; 2006 Feb; 20(2):115-21. PubMed ID: 16615420
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation of stage IA non-small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial.
Palussière J; Chomy F; Savina M; Deschamps F; Gaubert JY; Renault A; Bonnefoy O; Laurent F; Meunier C; Bellera C; Mathoulin-Pelissier S; de Baere T
J Cardiothorac Surg; 2018 Aug; 13(1):91. PubMed ID: 30143031
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of CT-guided percutaneous radiofrequency ablation of inoperable patients with stage Ia non-small cell lung cancer: A retrospective cohort study.
Huang BY; Li XM; Song XY; Zhou JJ; Shao Z; Yu ZQ; Lin Y; Guo XY; Liu DJ; Li L
Int J Surg; 2018 May; 53():143-150. PubMed ID: 29555533
[TBL] [Abstract][Full Text] [Related]
7. Fluorodeoxyglucose positron emission tomography for detection of tumor recurrence following radiofrequency ablation in retrospective cohort of stage I lung cancer.
Wang Y; Lanuti M; Bernheim A; Shepard JO; Sharma A
Int J Hyperthermia; 2018; 35(1):1-8. PubMed ID: 29719997
[TBL] [Abstract][Full Text] [Related]
8. The Maximum standardized uptake value is more reliable than size measurement in early follow-up to evaluate potential pulmonary malignancies following radiofrequency ablation.
Alafate A; Shinya T; Okumura Y; Sato S; Hiraki T; Ishii H; Gobara H; Kato K; Fujiwara T; Miyoshi S; Kaji M; Kanazawa S
Acta Med Okayama; 2013; 67(2):105-12. PubMed ID: 23603927
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation of non-small-cell carcinoma of the lung under real-time FDG PET CT guidance.
Schoellnast H; Larson SM; Nehmeh SA; Carrasquillo JA; Thornton RH; Solomon SB
Cardiovasc Intervent Radiol; 2011 Feb; 34 Suppl 2():S182-5. PubMed ID: 20508937
[TBL] [Abstract][Full Text] [Related]
10. CyberKnife radiosurgery for inoperable stage IA non-small cell lung cancer: 18F-fluorodeoxyglucose positron emission tomography/computed tomography serial tumor response assessment.
Vahdat S; Oermann EK; Collins SP; Yu X; Abedalthagafi M; Debrito P; Suy S; Yousefi S; Gutierrez CJ; Chang T; Banovac F; Anderson ED; Esposito G; Collins BT
J Hematol Oncol; 2010 Feb; 3():6. PubMed ID: 20132557
[TBL] [Abstract][Full Text] [Related]
11. Increase in fluorodeoxyglucose positron emission tomography activity following complete radiofrequency ablation of lung tumors.
Sharma A; Lanuti M; He W; Palmer EL; Shepard JA; Digumarthy SR
J Comput Assist Tomogr; 2013; 37(1):9-14. PubMed ID: 23321827
[TBL] [Abstract][Full Text] [Related]
12. Long-term Observation of CT-guided Radiofrequency Ablation of Lung Neoplasm in 476 Consecutive Patients by a Thoracic Surgical Service: A Single-institutional Experience.
Huang BY; Zhou JJ; Yu ZQ; Song XY; Lin Y; Li XM; Li L
Acad Radiol; 2017 Dec; 24(12):1517-1525. PubMed ID: 28888381
[TBL] [Abstract][Full Text] [Related]
13. [CT Guided Radiofrequency Ablation Followed Intratumoral Chemotherapy
in the Treatment of Early Stage Non-small Cell Lung Cancer].
Feng W; Li J; Han S; Tang J; Yao J; Cui Y; Wang C; Chen Z; Li X; Zhi X
Zhongguo Fei Ai Za Zhi; 2016 May; 19(5):269-78. PubMed ID: 27215455
[TBL] [Abstract][Full Text] [Related]
14. Dual time-point (18)F-FDG PET/CT to assess response to radiofrequency ablation of lung metastases.
Lafuente S; Fuster D; Arguis P; Granados U; Perlaza P; Paredes P; Vollmer I; Sánchez M; Lomeña F
Rev Esp Med Nucl Imagen Mol; 2016; 35(4):226-31. PubMed ID: 26848142
[TBL] [Abstract][Full Text] [Related]
15. Bronchoscopy-Guided Cooled Radiofrequency Ablation as a Novel Intervention Therapy for Peripheral Lung Cancer.
Koizumi T; Tsushima K; Tanabe T; Agatsuma T; Yokoyama T; Ito M; Kanda S; Kobayashi T; Yasuo M
Respiration; 2015; 90(1):47-55. PubMed ID: 26044954
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic yield of baseline and follow-up PET/CT studies in ablative therapy for non-small cell lung cancer.
Pou Ucha JL; Nogueiras Alonso JM; Alvarez Paez AM; Suarez Arfenoni BA; Puig AS; Lopez Lopez AM; Barandela Salgado J; Campos Villarino LM; Casal Rivas M; Guitian Iglesias R
Rev Esp Med Nucl Imagen Mol; 2012; 31(6):301-7. PubMed ID: 23084012
[TBL] [Abstract][Full Text] [Related]
17. Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients.
Pennathur A; Luketich JD; Abbas G; Chen M; Fernando HC; Gooding WE; Schuchert MJ; Gilbert S; Christie NA; Landreneau RJ
J Thorac Cardiovasc Surg; 2007 Oct; 134(4):857-64. PubMed ID: 17903496
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer.
Dupuy DE; DiPetrillo T; Gandhi S; Ready N; Ng T; Donat W; Mayo-Smith WW
Chest; 2006 Mar; 129(3):738-45. PubMed ID: 16537876
[TBL] [Abstract][Full Text] [Related]
19. Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy.
Burdick MJ; Stephans KL; Reddy CA; Djemil T; Srinivas SM; Videtic GM
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1033-9. PubMed ID: 20472359
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous CT-guided radiofrequency ablation as supplemental therapy after systemic chemotherapy for selected advanced non-small cell lung cancers.
Li X; Zhao M; Wang J; Fan W; Li W; Pan T; Wu P
AJR Am J Roentgenol; 2013 Dec; 201(6):1362-7. PubMed ID: 24261378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]